HC Wainwright & Co. Reiterates Buy on Vigil Neuroscience, Maintains $17 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Andrew Fein has reiterated a Buy rating on Vigil Neuroscience (NASDAQ:VIGL) and maintained a price target of $17.
August 14, 2024 | 10:32 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Andrew Fein has reiterated a Buy rating on Vigil Neuroscience and maintained a price target of $17.
The reiteration of a Buy rating and the maintenance of a $17 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100